During March 2-3, 2019, the First Sinocare Dealers Conference was unveiled in Delhi as scheduled. As part of Sinocare's ambition to expand overseas market in 2019, this ordering training embodied its development concept of "growing with earnest, and exploring market with dedication" in 2019 to take comprehensive measures from multiple dimensions to provide quality services for overseas customers and offer strong confidence to Indian partners.

This conference consists of two parts: dealers training, and dealer partners meeting.

During the dealer training, Sinocare's bio-team represented by Dr. Cai Xiaohua, Chief Scientist of Sinocare, and Mr. Xiang Bo, Director of International Market Sales of Sinocare, shared with Indian elite sales teams about the company's product planning, product analysis, brand ideas and market development plan so that they can better sell the products in the market and provide better after-sales services.

At the dealer partners meeting, the company's main product - Safe AQ Smart, has obtained great popularity from Indian agents and partners owing to the excellent quality. Just one hour after the sales policy for agents was released, it received more than 10 orders totaling more than 15 million Indian rupees.

At present, India has a population of over 1.3 billion and the number of people with diabetes exceeds 75 million. After five years of development in India by Sinocare International Sales Department, its sales performance has been continuously doubled. Thus, it has become an important part of the company's international market business.

Faced with the huge number of people with diabetes in India, Sinocare will always fulfill its social responsibility to introduce more high-quality products and solutions to India, and make its due contribution to the diabetes prevention and treatment.